BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12580832)

  • 1. An update on the controversies of tocolytic therapy for the prevention of preterm birth.
    Ingemarsson I; Lamont RF
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):1-9. PubMed ID: 12580832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preterm labor: current tocolytic options for the treatment of preterm labor.
    Jørgensen JS; Weile LK; Lamont RF
    Expert Opin Pharmacother; 2014 Apr; 15(5):585-8. PubMed ID: 24456411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for the Treatment and Prevention of Preterm Labor.
    Patel SS; Ludmir J
    Clin Perinatol; 2019 Jun; 46(2):159-172. PubMed ID: 31010553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
    Lyndrup J; Lamont RF
    Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of preterm delivery.
    Simhan HN; Caritis SN
    N Engl J Med; 2007 Aug; 357(5):477-87. PubMed ID: 17671256
    [No Abstract]   [Full Text] [Related]  

  • 6. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis.
    Haas DM; Caldwell DM; Kirkpatrick P; McIntosh JJ; Welton NJ
    BMJ; 2012 Oct; 345():e6226. PubMed ID: 23048010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of tocolytics used for the inhibition of preterm labour.
    Lamont CD; Jørgensen JS; Lamont RF
    Expert Opin Drug Saf; 2016 Sep; 15(9):1163-73. PubMed ID: 27159501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tocolytic therapy in threatened preterm labor].
    Kimber-Trojnar Z; Leszczyńska-Gorzelak B; Marciniak B; Bartosiewicz J; Oleszczuk J
    Ginekol Pol; 2010 Feb; 81(2):120-4. PubMed ID: 20232710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on tocolytic therapy.
    McCombs J
    Ann Pharmacother; 1995 May; 29(5):515-22. PubMed ID: 7655136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preterm labour management--an evidence--update.
    Piyamongkol W
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S154-7. PubMed ID: 21213513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in the pharmacotherapeutic management of spontaneous preterm labor.
    Kam KY; Lamont RF
    Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in tocolytic therapy.
    Katz VL; Farmer RM
    Clin Obstet Gynecol; 1999 Dec; 42(4):802-19. PubMed ID: 10572695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of preterm labor.
    Jeyabalan A; Caritis SN
    Clin Obstet Gynecol; 2002 Mar; 45(1):99-113. PubMed ID: 11862062
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocolysis and preterm labour.
    King JF
    Curr Opin Obstet Gynecol; 2004 Dec; 16(6):459-63. PubMed ID: 15534440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolysis for preterm labor: expert opinion.
    Hösli I; Sperschneider C; Drack G; Zimmermann R; Surbek D; Irion O;
    Arch Gynecol Obstet; 2014 Apr; 289(4):903-9. PubMed ID: 24385286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse and beneficial effects of tocolytic therapy.
    Pryde PG; Besinger RE; Gianopoulos JG; Mittendorf R
    Semin Perinatol; 2001 Oct; 25(5):316-40. PubMed ID: 11707019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.